Sign Up for Our Newsletter
Contact Donate

Chronic Lymphocytic Leukemia (CLL)

Program Status


Open – We are accepting applications for new and renewal patients. If your application for assistance is approved you can begin receiving funding immediately.

Maximum Award Level

 $7,500 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

 Patient must have Medicare insurance coverage and Medicare must cover the medication for which patient seeks assistance.
The medication must treat the disease directly.
Patient must reside and receive treatment in the United States.
Patient’s income must fall below 500% of the Federal Poverty Level.

Get Help With Your Treatment

Apply Online (Click Here) or call 1-866-316-PANF (7263)

Information About the Disease

Chronic Lymphocytic Leukemia (CLL) is caused by a change to the DNA of a single cell called a lymphocyte. CLL cells multiply and replace normal lymphocytes (white blood cells) in the marrow and lymph nodes. The effect of CLL on the body worsens over time as the number of CLL cells increases. When the number of CLL cells in the marrow is very high the body is less able to fight infection.

CLL is treated with chemotherapy or monoclonal therapy or a combination of the two. Chemotherapy is administered orally or through an IV and kills cancer cells. Monoclonal antibody therapy is administered through an IV and consists of man-made proteins that target CLL cells. When the protein attaches to the surface of a CLL cell the cell dies.

For more information visit the Leukemia and Lymphoma Society website or call 800-955-4572.